| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $2,059,464 | +$635,578 | 2,394,725 | +45% | CVI Investments, Inc. | 31 Dec 2025 |
As of 31 Dec 2025, 39 institutional investors reported holding 1,720,560 shares of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR). This represents 7.1% of the company’s total 24,189,141 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,720,560 | $1,336,933 | +$797,534 | $0.78 | 39 |
| 2025 Q3 | 624,408 | $773,221 | -$686,712 | $1.24 | 34 |
| 2025 Q2 | 928,766 | $1,477,067 | +$473,599 | $1.59 | 31 |
| 2025 Q1 | 635,473 | $947,155 | -$78,728 | $1.49 | 27 |
| 2024 Q4 | 606,234 | $2,424,129 | +$2,412,517 | $4.00 | 29 |